Toggle navigation
Home
Search
Services
Blog
Contact
About
Chemopreventive Studies Employing a Transgenic Mouse
Moon, R.
University of Illinois at Chicago, Chicago, IL, United States
Search 820 grants from R. Moon
Search grants from University of Illinois at Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Binaural Spectral Integration with Hearing Loss and Hearing Devices
Chrolactomycin and Okilactomycin: Novel Antitumor Agents
Grants for Programs for Physician Assistants
Phase II Trial of A New Fatty Acid Synthesis Inhibitor
Nonlinear Photonic Crystal Nanocavities and Waveguides
Recently added grants:
Protocol Review and Monitoring System
Shared Resource 01: Biomedical Informatics (BISR)
Shared Resource 02: Biospecimen Services (BSSR)
Shared Resource 03: Biostatistics (BSR)
Shared Resource 04: Clinical-Translational Science (CTSSR)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN055152-000
Application #
2302654
Study Section
Project Start
1995-09-30
Project End
Budget Start
1995-09-30
Budget End
1997-09-29
Support Year
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chicago
Department
Surgery
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Related projects
NIH 1999
N01 CN
Chemopreventive Studies Employing a Transgenic Mouse
Pezzuto, John M. / University of Illinois at Chicago
NIH 1998
N01 CN
Chemopreventive Studies Employing a Transgenic Mouse
Pezzuto, John M. / University of Illinois at Chicago
NIH 1995
N01 CN
Chemopreventive Studies Employing a Transgenic Mouse
Moon, R. / University of Illinois at Chicago
Publications
Kosmeder 2nd, J W; Pezzuto, J M
(2001)
Intermediate biomarkers.
Cancer Treat Res 106:31-61
Comments
Be the first to comment on this grant